Best of ASH 2025 by Lund
2026-01-20 15:00 - 19:00 (Europe/Paris)
At Best of ASH 2025, hematologists in Lund, Sweden present their top picks from the annual meeting of the American Society of Hematology (ASH) cutting through the volume to focus on data that change how we treat patients. Expect concise, expert-led updates on key trials, late-breaking abstracts, and their real-world implications across hematology.
Live on YouTube: https://www.youtube.com/live/DJrW-8hEHvI

Webinar - Innovations in AML care: Integrating Novel Treatments into Nordic Practice
2026-02-26 14:00 - 15:15 | https://www.namlg.org/event/webinar-innovations-in-aml-care/
The Nordic AML Group’s Educational Working Group invites you to a scientific webinar focusing on recent innovations in the treatment of AML and their implementation in Nordic clinical practice.
The webinar will feature three expert speakers covering:
– The evolving AML treatment landscape by professor Gail Roboz (New York)
– Early Nordic experience with new AML therapies and ongoing Nordic studies by professor Bjørn Tore Gjertsen (Bergen)
– Access pathways and future developments in AML care by associate professor Anne Louise Tølbøll Sørensen (Copenhagen)
Aim: To provide a clinically relevant and up-to-date overview of emerging therapeutic approaches for AML, with particular emphasis on feasibility, relevance, and early adoption within the Nordic region.
Format: Webinar via Zoom via this link
Sponsorship: Sponsored by Otsuka. The sponsor has no influence on the scientific content or agenda.
#################################
Agenda – 2026-02-26 – 14:00 – 15:15 (CET)
14:00 – 14:05 – Welcome & Introduction
14:05 – 14:20 – The Evolving AML Landscape, Professor Gail Roboz (New York)
14:20 – 14:35 – From Data to Practice: Early Nordic Experience with New AML Treatments, Professor Bjørn Tore Gjertsen (Bergen)
14:35 – 14:45 – Discussion
14:45 – 15:00 – Ongoing Nordic Studies, Access Pathways, and What’s Coming Next, Associate professor Anne Louise Tølbøll Sørensen (Copenhagen)
15:00 – 15:10 – Discussion
15:10 – 15:15 – Closing remarks
#################################

NAMLG – Steering group meeting
2026-03-03 16:00 - 17:00
Agenda and meeting link will be sent via e-mail.

Germline Predisposition to Myeloid Neoplasms - Case discussions
2026-03-05 15:00 - 16:00
Join the MDR for patients with germline predisposition for hematological malignancies.
This meeting is for clinicians within the Nordics via this Zoom-link.
If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.

Webinar - Ask the expert: FLT3 MRD testing in AML patients
2026-03-17 17:00 - 18:00
Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis, MD, PhD, Baltimore, USA, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda:
Assess the current minimal residual disease testing modalities/methods
 Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities
 Summarize the appropriate treatment strategies in a post-transplant setting
 Best practice sharing in developing/setting up FLT3 MRD testing
More info and register here.

Germline Predisposition to Myeloid Neoplasms – Case discussions
2026-05-07 15:00 - 16:00
Join the MDR for patients with germline predisposition for hematological malignancies.
This meeting is for clinicians within the Nordics.via this Zoom-link.
If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.

NAMLG meeting @ EHA2026
2026-06-13 00:30 - 14:00

AML Course Day 2026 - Bergen
2026-09-16 08:00 - 17:00

Nordic AML Meeting 2026 - Bergen
2026-09-17 - 2026-09-18
